Koninklijke Philips N.V., OMRON Corporation, BioTelemetry, Inc. and many others are dominating the market for Global Digital Health Monitoring Devices Market in 2018

Koninklijke Philips N.V.:

Koninklijke Philips N.V. founded in 1891 and headquartered in Eindhoven, Netherlands. The company offers products and services for mother and child care, and oral healthcare and many other worldwide. The company has its subsidiaries and they are Saeco International Group S.p.A. , Philips Lighting Holding B.V. , Magnavox Electronic Systems Co , VideoLand Inc., Luceplan S.p.Aand many others.

Access Full Report at : https://databridgemarketresearch.com/reports/global-digital-health-monitoring-devices-market/

The company has its presence in Europe, Latin America, Asia Pacific, Middle East & Africa, North America.

In October 2018, Philips launched IntelliVue Guardian Software app for patient monitoring. It is a new FDA-cleared as well as CE mark approved mobile app. This mobile app is called as IntelliVue Guardian Software. With this launch company has increased product portfolio and also one more option to their client in health monitoring devices market.

OMRON Corporation:

OMRON Corporation founded in 1933, headquartered in Kyoto Prefecture, Japan. The company is engaged in manufacturing and selling automation components, equipment and systems. The company has its business segment which are IAB, EMC, AEC ,HCB, SSB and other. The company has its presence in Japan, Greater China, and Europe, Americas, Southeast Asia and Others. The company has its subsidiaries and they are OMRON HEALTHCARE Co., Ltd., Omron Automation & Safety, Omron Healthcare Europe B.V., OMRON Corporation, Delta Tau Data Systems, Inc..

In April 2016, Omron Healthcare Co. Ltd. developed a continuous, noninvasive Beat. It works by using Beat blood pressure monitoring technology. The technology has proprietary pressure sensor enables measurement of blood pressure for every heartbeat by attaching the monitor unit on the wrist. With this development the company increased their product portfolio. 

BioTelemetry, Inc.:

BioTelemetry, Inc. founded in 2013, headquartered in Pennsylvania, U.S. and engaged in providing cardiac and mobile blood glucose monitoring (BGM), centralized medical imaging, and services. The company has it business segment and they are Healthcare, Research and other. The company has its subsidiaries and they are CardioNet, Inc., Mednet Healthcare Technologies, Inc., Cardiocore, LLC, LifeWatch AG (Switzerland), VirtualScopics, Inc.

The company has its presence in United States, United Kingdom and Japan.

In June 2018, BioTelemetry, Inc. launched its next-generation wireless blood glucose monitor for diabetes management. With this launch there is an achievement in product portfolio of the company due to addition to this new product.